Oruc, Z. Et Al. 2019. Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre study. JOURNAL OF BUON , vol.24, no.5 , 1876-1883.

Oruc, Z., Kaplan, M. A., Geredeli, C., Sari, N. Y., Ozaslan, E., Aytekin, A., ... ELKIRAN, E. T.(2019). Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre study. JOURNAL OF BUON , vol.24, no.5, 1876-1883.

Oruc, Zeynep Et Al. "Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre study," JOURNAL OF BUON , vol.24, no.5, 1876-1883, 2019

Oruc, Zeynep Et Al. "Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre study." JOURNAL OF BUON , vol.24, no.5, pp.1876-1883, 2019

Oruc, Z. Et Al. (2019) . "Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre study." JOURNAL OF BUON , vol.24, no.5, pp.1876-1883.

@article{article, author={Zeynep Oruc Et Al. }, title={Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre study}, journal={JOURNAL OF BUON}, year=2019, pages={1876-1883} }